Preclinical evaluation of Ayurveda and Siddha Herbo-mineral formulations in cancer: A scoping review protocol
PLOS One · 14.08.2026 · 21 (8) · e0355873
DOI: 10.1371/journal.pone.0355873 ↗Kurz gefasst
Scoping Review in der Zeitschrift PLOS One, online erschienen am 14.08.2026. Verfasst von Anjali Saini und 1 weiteren Autor:innen. Beteiligte Einrichtung: All India Institute of Ayurveda, New Delhi, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Medicine, Ayurvedic, Minerals, Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cancer poses a major global health challenge, with rising incidence and mortality rates straining healthcare systems worldwide. Despite remarkable advances in cancer management modalities, the current approaches still fall short in overcoming drug resistance, tumour heterogeneity, toxicity and side effects. Traditional systems such as Ayurveda and Siddha may help overcome these limitations of conventional medicine; however, robust evidence supporting the anticancer efficacy of Herbo mineral formulations (HMFs) remains limited and fragmented.
Objective
This scoping review is planned to map the existing pre-clinical evidence from in vitro and in vivo studies for the anticancer activities of Ayurveda and Siddha HMFs.
Methods
The scoping review will be conducted in accordance with the framework proposed by Arksey and O’Malley and the recommendations of the Joanna Briggs Institute for conducting scoping reviews. A systematic search will be conducted by two independent reviewers across selected databases for relevant literature, and studies will be selected on the basis of predefined eligibility criteria. Data from the included studies will be presented in tabular and narrative formats to align with the review objectives. The review will be reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines.
Discussion
This review will contribute to integrating traditional medicine with modern oncology, guiding researchers and clinicians in prioritizing promising anticancer drugs for further investigation and potential therapeutic use. The review protocol was registered with the Open Science Framework (OSF) and is available at: osf.io/rdhpv/.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- All India Institute of Ayurveda, New Delhi, India.
ORCID-Profile: Shalini Rai
Zitieren
APA
Saini, A., & Rai, S. (2026). Preclinical evaluation of Ayurveda and Siddha Herbo-mineral formulations in cancer: A scoping review protocol. PLOS One, 21(8), e0355873. https://doi.org/10.1371/journal.pone.0355873
Vancouver
Saini A, Rai S. Preclinical evaluation of Ayurveda and Siddha Herbo-mineral formulations in cancer: A scoping review protocol. PLOS One. 2026;21(8):e0355873. doi:10.1371/journal.pone.0355873
BibTeX
@article{Saini2026,
author = {Saini, Anjali and Rai, Shalini},
title = {Preclinical evaluation of Ayurveda and Siddha Herbo-mineral formulations in cancer: A scoping review protocol},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {8},
pages = {e0355873},
doi = {10.1371/journal.pone.0355873}
}
EUVIMED